Here are five details:
1. Per the agreement, Kico Knee will market and distribute Implanet’s Madison Knee prosthesis.
2. The agreement will initially cover high-potential markets of the U.S. and Australia on a non-exclusive basis.
3. Once it hits the threshold of 1,000 Madison implants within a one-year period, Kico will then gain exclusive rights to Madison knee prosthesis as well as an option for a manufacturing license.
4. Designed to tailor each knee replacement procedure to the individual, Kico implants are created over a series of stages, including pre-operative patient profiling, creation of a patient-specific rehabilitation program and generation of 3D surgical plans.
5. More than 17,000 Madison knee prostheses have been implanted since 2010, Implanet CEO Ludovic Lastennet said.
More articles on devices and implants:
Spine Injury Solutions posts $561K Q3 revenue: 5 highlights
Global surgical navigation system market CAGR to increase 4.4%
Medtronic to expand Ireland offices: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
